RedHill Biopharma Adds Israel Rights to Movantik From AstraZeneca - Seite 4
Company contact: Adi Frish Senior VP Business Development & Licensing RedHill Biopharma +972-54-6543-112 adi@redhillbio.com |
IR contact (U.S.): Timothy McCarthy, CFA, MBA Managing Director, Relationship Manager LifeSci Advisors, LLC +1-212-915-2564 tim@lifesciadvisors.com |
_______________
i Full prescribing information for Movantik (naloxegol) is available at: www.Movantik.com; Approved in Israel under brand name Moventig.
ii Crockett, Seth D., et al. American Gastroenterological Association Institute guideline on the medical management of opioid-induced
constipation, Gastroenterology 156.1 (2019): 218-226.
iii Full prescribing information for Movantik (naloxegol) is available at: www.Movantik.com.
iv Full
prescribing information for Talicia (omeprazole magnesium, amoxicillin and rifabutin) is available at: www.Talicia.com.
v Full prescribing information for Aemcolo (rifamycin) is available at: www.Aemcolo.com.
Lesen Sie auch
Diskutieren Sie über die enthaltenen Werte
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte